Home > News > Asensio Announces Investment Opinion on NVE
April 2nd, 2004
Asensio Announces Investment Opinion on NVE
Today Asensio & Company, Inc., with 12 years of experience as a leading independent equity research firm, published two research reports on NVE Corporation (NASDAQ Symbol: NVEC, $50.83) titled "NVEC fails to solve Cypress' MRAM problems" and "Cypress values NVEC at a maximum of $4.85 per share."
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014